Subscribe
Home Economics US pharma giant buys Germany’s Celesio in $8-bn deal

US pharma giant buys Germany’s Celesio in $8-bn deal

When you purchase through our sponsored links, we may earn a commission. By using this website you agree to our T&Cs.

US pharma giant buys Germany’s Celesio in $8-bn deal (via AFP)

US pharmaceutical distributor McKesson on Thursday announced the purchase of German rival Celesio in a deal valued at more than $8 billion. The combined company “will be one of the largest pharmaceutical wholesalers and providers of logistics and services…

Our Editorial Standards

At ValueWalk, we’re committed to providing accurate, research-backed information. Our editors go above and beyond to ensure our content is trustworthy and transparent.

AFP
Editor

Related news

S&P 500 Hits All-Time High as Q2 Earnings Season Kicks Off
Dave Kovaleski
Inflation rate
Inflation Falls to 3% in June – A Kickstarter for Rate Cuts?
Dave Kovaleski
Jerome Powell discussed interest rate decisions
Fed Chair Jerome Powell: “Two-Sided Risks” to Interest Rate Decisions
Dave Kovaleski
FOMC Member
There are ‘Several Reasons’ to Be Optimistic About Inflation, According to FOMC Member
Dave Kovaleski
Inflation Rates
How Low Will Inflation Rates Be One Year From Now?
Dave Kovaleski

Must Read

New

How to Invest in Stocks in 2024 – Beginner’s Guide

Investing in stocks can be a great way to improve your overall wealth – but...

23 Min Read Read now

Latest News

asml
News

ASML Stock Plunges Despite Q2 Beat - What Now?
Aman Jain3 hours

Global chip stocks have collectively suffered this week amid rising geopolitical tensions Dutch chipmaker ASML Holdings' (AMS: ASML) stock fell more than 10% Wednesday despite Q2 earnings and sales that...

Categories

Want Financial Guidance Sent Straight to You?

  • Pop your email in the box, and you'll receive bi-weekly emails from ValueWalk.
  • We never send spam — only the latest financial news and guides to help you take charge of your financial future.